CAR T cell therapy for breast cancer: harnessing the tumor milieu to drive T cell activation-Reference-Cited by-同舟云学术

CAR T cell therapy for breast cancer: harnessing the tumor milieu to drive T cell activation

Published:2018-05-10 Issue:1 Volume:6 Page:
ISSN:2051-1426
Container-title:Journal for ImmunoTherapy of Cancer
language:en
Short-container-title:j. immunotherapy cancer

Author:

Bajgain Pradip,Tawinwung Supannikar,D’Elia Lindsey,Sukumaran Sujita,Watanabe Norihiro,Hoyos Valentina,Lulla Premal,Brenner Malcolm K.,Leen Ann M.,Vera Juan F.

Funder

National Cancer Institute

Pancreatic Cancer Action Network

American Cancer Society

Cancer Prevention and Research Institute of Texas

V Foundation for Cancer Research

Elsa U. Pardee Foundation

Adrienne Helis Malvin Medical Research Foundation

Publisher

BMJ

Subject

Cancer Research,Pharmacology,Oncology,Molecular Medicine,Immunology,Immunology and Allergy

Link

http://link.springer.com/content/pdf/10.1186/s40425-018-0347-5.pdf

Reference58 articles.

1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2017. CA Cancer J Clin. 2017;67(1):7–30. https://doi.org/10.3322/caac.21387 .

2. Brentjens RJ, Davila ML, Riviere I, Park J, Wang X, Cowell LG, Bartido S, Stefanski J, Taylor C, Olszewska M, et al. CD19-targeted T cells rapidly induce molecular remissions in adults with chemotherapy-refractory acute lymphoblastic leukemia. Sci Transl Med. 2013;5(177):177ra38. https://doi.org/10.1126/scitranslmed.3005930 .

3. Grupp SA, Kalos M, Barrett D, Aplenc R, Porter DL, Rheingold SR, Teachey DT, Chew A, Hauck B, Wright JF, et al. Chimeric antigen receptor-modified T cells for acute lymphoid leukemia. N Engl J Med. 2013;368(16):1509–18. https://doi.org/10.1056/NEJMoa1215134 .

4. Kalos M, Levine BL, Porter DL, Katz S, Grupp SA, Bagg A, June CH. T cells with chimeric antigen receptors have potent antitumor effects and can establish memory in patients with advanced leukemia. Sci Transl Med. 2011;3(95):95ra73. https://doi.org/10.1126/scitranslmed.3002842 .

5. Porter DL, Levine BL, Kalos M, Bagg A, June CH. Chimeric antigen receptor-modified T cells in chronic lymphoid leukemia. N Engl J Med. 2011;365(8):725–33. https://doi.org/10.1056/NEJMoa1103849 .

Cited by 84 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advanced Strategies of CAR-T Cell Therapy in Solid Tumors and Hematological Malignancies;Recent Patents on Anti-Cancer Drug Discovery;2024-12

2. Harnessing the tumor microenvironment to boost adoptive T cell therapy with engineered lymphocytes for solid tumors;Seminars in Immunopathology;2024-07-25

3. Incorporating IL7 receptor alpha signaling in the endodomain of B7H3-targeting chimeric antigen receptor T cells mediates antitumor activity in glioblastoma;Cancer Immunology, Immunotherapy;2024-04-15

4. Targeting Interleukin-13 Receptor α2 and EphA2 in Aggressive Breast Cancer Subtypes with Special References to Chimeric Antigen Receptor T-Cell Therapy;International Journal of Molecular Sciences;2024-03-28

5. A dual-luciferase bioluminescence system for the assessment of cellular therapies;Molecular Therapy: Oncology;2024-03